Dear Readers,
During the second wave of the COVID-19 pandemic in India, an unique surge in cases of mucormycosis was observed. This site news brief about the mucormycosis and evaluated clinical features, predisposing factors, diagnosis, and outcomes for mucormycosis among patients with COVID-19 infection. Your feedback will help us improve the newsletter. Please send in your feedback at eyesite@aravind.orgThank You. Have a happy reading. Regards, Library Team |
|
- MUCORMYCOSIS
WHO webpage contains the infographic details of mucormycosis.
- MUCORMYCOSIS - FUNGAL DISEASES
This article describes in brief about the mucormycosis causes, symptom risk, preventions, and treatment availability.
- WHAT IS THE PREVALENCE OF MUCORMYCOSIS (ZYGOMYCOSIS)
This article gives the details of the prevalence of mucormycosis.
- MUCORMYCOSIS STATISTICS
This Population-based study provided the incidence estimates for mucormycosis were obtained from laboratory surveillance in the San Francisco Bay Area during 1992–1993 and suggested a yearly rate of 1.7 cases per 1 million populations.
- EPIDEMIOLOGY AND TREATMENT OF MUCORMYCOSIS
A US-based population survey performed in the early 1990s estimated an annual incidence of 1.7 mucormycosis cases per 1 million.
- SYMPTOMS OF MUCORMYCOSIS - CDC
This webpage provides the details about Cutaneous (skin) mucormycosis and other symptoms include pain, warmth, excessive redness, or swelling around a wound.
- SEVEN POINTS YOU SHOULD KNOW ABOUT MUCORMYCOSIS
This article pointed out the diagnosis and treatment of mucormycosis.
- WHAT IS BEHIND THE DEADLY RISE IN MUCORMYCOSIS INFECTIONS IN INDIA
The aim of this study was to estimate the prevalence of Mucor and what conditions make India more hospitable to it than other countries in Southeast Asia.
- EPIDEMIOLOGY AND TREATMENT OUTCOME OF MUCORMYCOSIS IN KHUZESTAN, SOUTHWEST OF IRAN
This study aimed to determine the epidemiology, treatment and outcome of mucormycosis in Khuzestan province, Southwest of Iran.
- MUCORMYCOSIS - AN OVERVIEW
This article focuses on causes and treatment of Mucormycosis .AND reliant on reversal of underlying predisposing factors, surgical debridement of infected tissues, and appropriate anti fungal therapy.
- MUCORMYCOSIS (ZYGOMYCOSIS)
Mucormycosis is a fungal infection caused by fungi of the class Zygomycetes. These fungal infections are not common and most frequently occur in people with another form of debilitating illness.
- PULMONARY MUCORMYCOSIS: THE LAST 30 YEARS
This article describes a recent case and review the literature to delineate the clinical characteristics of Mucormycosis infection.
|
|
You can also refer your friends to register with the innovative resources. Send in your friend's e-mail id to us at eyesite@aravind.org with the subject line Register my friend's id!
Subscribe Sitenews
If you want to unsubscribe from our mailing list and from all our communications please click on the following link:
Unsubscribe Sitenews
Address:
Vision 2020 e-resource team,
Lions Aravind Institute of Community Ophthalmology,
1, Annanagar, Madurai - 625 020,
Tamil Nadu, India,
E-mail:eyesite@aravind.org
Phone: 91-452-2537580
| |
|
MUCORMYCOSIS
MUCORMYCOSIS AND COVID-19
MUCORMYCOSIS – COVID-19 & EYE
VIDEOS
Talk To Us 